Service d'Anesthésie, Réanimation et Médecine péri-Opératoire - CHU de Strasbourg - France
Strasbourg, 67091, France
NCT Number: NCT05546970
Pancreatic duodenectomy is one of the treatments offered to patients with neoplastic disease of the pancreas. In France, in 2018, 14,000 duodeno-pancreatectomies were performed, including 140 at the Hautepierre hospital at the Strasbourg University Hospital. Pancreaticoduodenectomy is a major surgery, causing significant postoperative pain that should be minimized through multimodal analgesia involving in particular locoregional anesthesia. Since 2019, the recommendations of the ERAS company concerning ERAS (Improved Rehabilitation After Surgery) after pancreaticoduodenectomy recommend the establishment of thoracic epidural analgesia in order to limit postoperative pain. When there is a contraindication to the placement of a thoracic epidural, in particular due to arterial and/or venous vascular reconstructions requiring potential perioperative curative anticoagulation, the administration of local anesthetic by pericatricial catheter is recommended. recommended. The Transversus Abdominis Plane (TAP) block has proven analgesic efficacy, safety and harmlessness in colorectal surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Strasbourg, 67091, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Morphine consumption in the first 24 postoperative hours
University Hospital, Strasbourg, France
Other
Efficacy of the Transversus Abdominis Plane Block (TAP-Block) on Analgesia After Cephalic Duodeno-pancreatectomy
Acronym: TAP-Block
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05722223
Behavior, Digestive System Diseases
Majadahonda, Madrid, Spain
View Trial DetailsNCT03535727
Adenocarcinoma, Carcinoma
Baltimore, Maryland, United States
View Trial DetailsNCT01964430
Adenocarcinoma, Antimetabolites, Antineoplastic
Scottsdale, Arizona, United States
View Trial DetailsNCT02810418
Digestive System Diseases, Digestive System Neoplasms
Bethesda, Maryland, United States
View Trial Details